Skip to content
Trial Eligibility
Menu

A Study to Evaluate BMS-986511 in Adults With Major Depressive Disorder

NCT07772531

This study is recruiting at 3 US sites in 2 states, according to its ClinicalTrials.gov record last updated .

Summary

A Study to Evaluate BMS-986511 in Adults with Major Depressive Disorder

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Major Depressive Disorder

Eligibility basics and study details

Study type
Interventional
Phase
Phase 2
Ages
18 to 65 years
Sex
All
Healthy volunteers
Not accepted
Sponsor
Bristol-Myers Squibb
Last updated on ClinicalTrials.gov
November 18, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Arkansas · 2

  • Woodland International Research Group · Little Rock, AR
  • Woodland Research Northwest LLC · Rogers, AR

Georgia · 1

  • CenExel CBH · Atlanta, GA

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.